Loading...
Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
OBJECTIVE: To investigate the statistical power of plasma, imaging, and cognition biomarkers as Alzheimer’s disease (AD) clinical trial outcome measures. METHODS: Plasma neurofilament light, structural magnetic resonance imaging, and cognition were measured longitudinally in the Alzheimer’s Disease...
Na minha lista:
| Udgivet i: | Ann Clin Transl Neurol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7480920/ https://ncbi.nlm.nih.gov/pubmed/32779869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.51158 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|